Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other Accumulated Expenses (2021 - 2022)

Cullinan Therapeutics has reported Other Accumulated Expenses over the past 2 years, most recently at $2.0 million for Q4 2022.

  • Quarterly results put Other Accumulated Expenses at $2.0 million for Q4 2022, up 100.92% from a year ago — trailing twelve months through Dec 2022 was $2.0 million (up 100.92% YoY), and the annual figure for FY2022 was $2.0 million, up 100.92%.
  • Other Accumulated Expenses for Q4 2022 was $2.0 million at Cullinan Therapeutics, up from $973000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for CGEM hit a ceiling of $2.0 million in Q4 2022 and a floor of $973000.0 in Q4 2021.